Swedish Medicines Verification Organisation (e-VIS)

What Swedish Medicines Verification Organisation (e-VIS) does

The Swedish Medicines Verification Organisation (e-VIS) is a Swedish non-profit, privately held organisation founded in 2016 to operate the country's national medicines e-verification system. According to its stated purpose, e-VIS exists to prevent falsified medicines from entering or moving through the Swedish pharmaceutical supply chain by authenticating medicines through a national e-verification infrastructure. The organisation serves the Swedish medicines market, providing the national node that links pharmaceutical manufacturers, wholesalers, pharmacies, and hospitals into a shared authentication network.

e-VIS maintains a small operational team of 1–10 employees, consistent with its mandate as a dedicated national verification operator rather than a commercial software vendor. Its core offering is the e-verification system hosted at e-vis.se, which is designed to check medicine pack identifiers against an authoritative database. Specific technology architecture, APIs, SDKs, or proprietary features are not disclosed in the available source material; the firm's primary web page returned only a generic loading/verification page during data collection, and no app, AI/ML capability, or integration catalogue is documented. The organisation holds no patents, trademarks, awards, partnerships, or compliance certifications disclosed in available sources.

As a non-profit, e-VIS's funding model and pricing structure are not publicly detailed in the source data. The organisation does not disclose revenue, customer pricing, or contractual terms. Its operating geographies, office locations, named customers, customer segments, management team, and ownership structure are likewise undocumented in the available source material, limiting further strategic or financial granularity. Given the EU-wide regulatory context in which such national verification organisations are typically established, e-VIS most plausibly operates on a fee-based model funded by pharmaceutical manufacturers, but this cannot be confirmed from the supplied data.

Name

Swedish Medicines Verification Organisation (e-VIS)

Website

https://e-vis.se

Company type

Private

Founded year

2016

Headcount range

1–10 employees

Short description

Swedish Medicines Verification Organisation (e-VIS) is a non-profit founded in 2016 that operates Sweden's national medicines e-verification system to prevent falsified medicines from entering the Swedish pharmaceutical supply chain, serving stakeholders across the country's medicines distribution ecosystem.

Ownership category

akta.pro rank

Product category

Pharmaceutical Supply Chain Security

NAICS

Testing Laboratories and Services (541380)

SIC

Services-Health Services (8000)

akta.pro industry

PRIMARYIMALAIAJ

Anti-Counterfeit & Track-and-Trace Packaging (Serialization, Security Features)

Industrials, Manufacturing & Construction/Packaging & Containers/Pharmaceutical & Medical Packaging

SECONDARYHLAJADAI

Regulatory Affairs, Labeling & Advertising/Promotion Compliance

Healthcare & Life Sciences/Public Health, Government & Regulators/Medicines & Healthcare Product Regulators (Drugs/Biologics/Devices)

Keywords

• Pharmaceutical verification
• Medicines authentication
• Falsified medicines prevention
• Pharmaceutical supply chain security
• Prescription drug verification

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations

Core offering

e-VIS operates the Swedish national medicines e-verification system used to prevent falsified medicines from entering the legitimate pharmaceutical supply chain. It is a non-profit system operator that enables pharmaceutical manufacturers, wholesalers, and pharmacies to authenticate prescription medicines through an interoperable, EU Falsified Medicines Directive-aligned electronic verification platform in Sweden.

Differentiator

Problem solved

Functional benefit

Products and services

• Swedish Medicines Verification System (e-verification platform) National e-verification platform that authenticates prescription medicines in Sweden to prevent falsified medicines from entering the legitimate supply chain; used by licensed pharmaceutical manufacturers, wholesalers, parallel distributors, and pharmacies to serialize, verify, and decommission medicine packs in accordance with EU FMD requirements.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Emerging players

• TraceLink: Global pharmaceutical supply-chain serialization and traceability platform serving manufacturers and wholesalers interacting with NMVS systems like the one operated by e-VIS. Comparable as ecosystem participant in pharmaceutical verification.
• Movilitas: Specialist consultancy and technology provider for pharmaceutical serialization and traceability, working with manufacturers and NMVO stakeholders. Adjacent comparator for the regulatory serialization ecosystem e-VIS operates in.
• Antares Vision: Provider of serialization, track-and-trace, and pharmaceutical inspection systems that integrate with NMVS infrastructure across Europe. Comparable as a technology ecosystem participant serving the same pharmaceutical verification value chain as e-VIS.

Direct peers

• DMVO (Dansk Medicin Verifikation Organisation): Danish national medicines verification organisation operating Denmark's NMVS. Directly comparable in mandate and Nordic context, and another small-scale national MVO peer to e-VIS.
• InfoMed (Spain): Spanish organisation supporting Spain's medicines verification system under the EU FMD. Comparable national-system peer, though operating in a much larger market with greater transaction volume.
• securPharm e.V. German national medicines verification organisation operating the German NMVS under the EU Falsified Medicines Directive. Closest functional peer to e-VIS, with the same mandate, structure (non-profit stakeholder organisation), and underlying technology stack.
• Stichting Nationaal Medicines Verification Organisation (NMVO NL): Dutch national medicines verification organisation running the Netherlands' NMVS. Directly comparable to e-VIS in mandate, structure, and operating model — one of the most relevant national-system peers.
• FiMVO (Finnish Medicines Verification Organisation): Finnish national medicines verification organisation with the same EU FMD mandate, non-profit structure, and Nordic regulatory environment as e-VIS. Highly comparable in scale and operating approach.

Others

• Arvato Systems: Technology vendor that has provided the verification platform for multiple national MVOs across Europe, including systems used by e-VIS. Comparable as the underlying infrastructure provider in the same medicines-verification value chain.

Broad incumbents

• European Medicines Verification Organisation (EMVO): Pan-European umbrella organisation that coordinates the EU-wide medicines verification system and links national MVOs like e-VIS into a single hub. Comparable at the framework level and the parent governance body for e-VIS-style national organisations.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/swedish-medicines-verification-organisation-e-vis

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Swedish Medicines Verification Organisation (e-VIS)